Gamma-secretase: substrates and inhibitors

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Alzheimer's disease (AD) is a common dementia linked to amyloid beta-protein (Abeta) deposits.
• Abeta is proteolytically derived from the amyloid precursor protein (APP) via beta- and gamma-secretase cleavage.
• Gamma-secretase activity is central to AD pathogenesis, making it a key therapeutic target.

Purpose of the Study:

• To investigate the role and therapeutic potential of gamma-secretase in Alzheimer's disease.
• To explore the broader substrate specificity and cellular functions of gamma-secretase beyond APP.

Main Methods:

• The study focuses on the enzymatic activity and substrate processing of gamma-secretase.
• Analysis of gamma-secretase cleavage events on APP and other relevant proteins like Notch and ErbB4.
• Investigating the membrane-associated nature and substrate-dependent cleavage site determination of gamma-secretase.

Main Results:

• Gamma-secretase performs sequential cleavages on APP to generate Abeta.
• Gamma-secretase also cleaves other critical proteins, including Notch and ErbB4, involved in cell signaling.
• All identified gamma-secretase substrates are implicated in nuclear signaling pathways.

Conclusions:

• Gamma-secretase is a critical enzyme in Abeta production and a significant therapeutic target for Alzheimer's disease.
• The diverse substrate profile of gamma-secretase suggests broader roles in cellular processes beyond amyloid metabolism.
• Understanding gamma-secretase's function in nuclear signaling pathways is vital for developing effective pharmacological interventions.